加载中
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
常规交易时段
US$2.83
−US$0.0739 · -2.54%
盘中时间采用ET。市场数据可能有所延迟。
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
日内区间
当前US$2.83
52周区间
当前US$2.83
盘中时间采用ET。市场数据可能有所延迟。
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
日内区间
当前US$2.83
52周区间
当前US$2.83
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 销货成本 | — | 3321 USD | 1.14万 USD | 1.14万 USD | 1.01万 USD |
| 毛利 | — | −3321 USD | −1.14万 USD | −1.14万 USD | −1.01万 USD |
| 研究与开发 | 112.6万 USD | 42.21万 USD | 590.83万 USD | 897.66万 USD | 591.95万 USD |
| 销售、一般及管理费用 | 134.8万 USD | 321.42万 USD | 589.88万 USD | 649.43万 USD | 593.11万 USD |
| 营业费用 | 247.4万 USD | 438.01万 USD | 1180.71万 USD | 1547.1万 USD | 1185.06万 USD |
| 利息收入 | 36.9万 USD | — | — | 100.87 USD | 68.13 USD |
| 利息支出 | 600.8万 USD | 15万 USD | 14.52万 USD | 10.09万 USD | 6.81万 USD |
| 折旧和摊销 | 5.5万 USD | 3321 USD | 1.14万 USD | 1.14万 USD | 1.01万 USD |
| 营业利润 | −247.4万 USD | −438.01万 USD | −1180.71万 USD | −1548.24万 USD | −1186.06万 USD |
| 净利润 | −830万 USD | −198.08万 USD | −1217.2万 USD | −1649.57万 USD | −1194.61万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
